Callan Family Office Portfolio holdings
Callan Family Office is an independent wealth manager for ultra-high-net-worth families, foundations and endowments, launched in 2022 by former Wells Fargo executives. Its chief executive, Jack Ginter, was previously president of Abbot Downing, a Wells Fargo business, and started the firm with Amy Jucoski, a former Abbot Downing senior director of planning. It licenses the Callan name and draws on research from Callan LLC, an investment consulting firm, but the two firms are not affiliated.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$8.35M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.61M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.26M |
| 4 |
Apple
AAPL
|
+$6.39M |
| 5 |
NVIDIA
NVDA
|
+$5.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$5.06M |
| 2 |
Western Digital
WDC
|
+$3.02M |
| 3 |
Edwards Lifesciences
EW
|
+$2.63M |
| 4 |
Honeywell
HON
|
+$2.41M |
| 5 |
Blackstone
BX
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.4% |
| 2 | Miscellaneous | 22.68% |
| 3 | Financials | 11.9% |
| 4 | Industrials | 8.85% |
| 5 | Healthcare | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.99T
| $201M | 3.93% |
1,004,009
+27,745
| +3% | +$5.7M |
2023 Q4
10 quarters
|
|
|
2
Apple
AAPL
$4.84T
| $178M | 3.47% |
613,564
+22,355
| +4% | +$6.39M |
2022 Q4
14 quarters
|
|
|
3
iShares Core S&P 500 ETF
IVV
$869B
| $159M | 3.11% |
212,091
+11,463
| +6% | +$8.35M |
2022 Q4
14 quarters
|
|
4
Microsoft
MSFT
$3.87T
| $128M | 2.51% |
344,079
+840
| +0.2% | +$340K |
2022 Q4
14 quarters
|
|
5
Vanguard S&P 500 ETF
VOO
$1.02T
| $123M | 2.4% |
178,743
-971
| -0.5% | -$647K |
2022 Q4
14 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$3.42T
| $120M | 2.35% |
339,487
-232
| -0.1% | -$82.9K |
2022 Q4
14 quarters
|
|
7
Amazon
AMZN
$2.71T
| $108M | 2.12% |
454,551
+2,477
| +0.5% | +$622K |
2022 Q4
14 quarters
|
|
|
8
iShares Core MSCI EAFE ETF
IEFA
$189B
| $105M | 2.05% |
1,086,316
+79,275
| +8% | +$7.61M |
2022 Q4
14 quarters
|
|
9
Alphabet (Google) Class A
GOOGL
$3.44T
| $89.6M | 1.75% |
250,823
+9,943
| +4% | +$3.58M |
2024 Q1
9 quarters
|
|
10
Broadcom
AVGO
$1.59T
| $80.4M | 1.57% |
212,834
+10,711
| +5% | +$4.29M |
2024 Q2
8 quarters
|
|
11
Vanguard Russell 3000 ETF
VTHR
$4.84B
| $72.6M | 1.42% |
219,190
-3,443
| -2% | -$1.1M |
2025 Q4
2 quarters
|
|
12
Eli Lilly
LLY
$1.26T
| $65.6M | 1.28% |
54,722
+1,768
| +3% | +$1.81M |
2024 Q1
9 quarters
|
|
13
Micron Technology
MU
$967B
| $56.3M | 1.1% |
48,762
-613
| -1% | -$460K |
2024 Q4
6 quarters
|
|
14
TSMC
TSM
$2.1T
| $53.6M | 1.05% |
112,327
-3,027
| -3% | -$1.23M |
2022 Q4
14 quarters
|
|
15
Meta Platforms (Facebook)
META
$1.62T
| $49.8M | 0.97% |
88,465
-697
| -0.8% | -$426K |
2024 Q2
8 quarters
|
|
16
Visa
V
$786B
| $48.4M | 0.95% |
141,136
+8,788
| +7% | +$2.82M |
2023 Q4
10 quarters
|
|
17
ASML
ASML
$598B
| $45.5M | 0.89% |
22,855
-254
| -1% | -$404K |
2024 Q1
9 quarters
|
|
18
iShares Russell 1000 Growth ETF
IWF
$120B
| $41M | 0.8% |
330,408
+12,180
| +4% | +$1.47M |
2022 Q4
14 quarters
|
|
19
Invesco QQQ Trust
QQQ
$463B
| $41M | 0.8% |
55,700
+300
| +0.5% | +$206K |
2022 Q4
14 quarters
|
|
20
Tesla
TSLA
$1.57T
| $41M | 0.8% |
97,519
-2,968
| -3% | -$1.18M |
2024 Q3
7 quarters
|
|
21
State Street SPDR S&P 500 ETF Trust
SPY
$798B
| $39.9M | 0.78% |
53,392
+36
| +0.1% | +$26.1K |
2022 Q4
14 quarters
|
|
22
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $39.6M | 0.77% |
513,069
+9,660
| +2% | +$709K |
2022 Q4
14 quarters
|
|
23
Advanced Micro Devices
AMD
$791B
| $37.8M | 0.74% |
65,046
+4,245
| +7% | +$1.74M |
2024 Q4
6 quarters
|
|
24
GE Aerospace
GE
$333B
| $36.9M | 0.72% |
98,688
+2,655
| +3% | +$831K |
2024 Q3
7 quarters
|
|
25
JPMorgan Chase
JPM
$897B
| $33.5M | 0.66% |
102,480
+1,557
| +2% | +$484K |
2022 Q4
14 quarters
|
|
Similar funds
Callan Family Office's Q2 2026 Portfolio in Review
As of Q2 2026, Callan Family Office held 1,262 positions worth $5.11B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Callan Family Office's Q2 2026 filing shows 131 new, 621 increased, 431 reduced and 36 closed positions. Its largest new stake was SpaceX: 20,977 shares worth $3.58M. The largest sale was Sanofi, an estimated $5.06M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Financials.
- Callan Family Office's largest Q2 2026 buy was SpaceX: 20,977 shares worth $3.58M.
- Callan Family Office added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $8.35M increase.
- Callan Family Office's biggest Q2 2026 reduction was Sanofi, cutting an estimated $5.06M.
- Callan Family Office fully exited Coterra Energy in Q2 2026, selling an estimated $1.28M.
- Callan Family Office's ten largest holdings make up 25% of its $5.11B portfolio in Q2 2026.
- Callan Family Office opened 131 new positions and closed 36 in Q2 2026.
- Callan Family Office's portfolio value rose 16% quarter-over-quarter to $5.11B.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.